Nissay Asset Management Corp Japan Raises Stock Position in Danaher Corporation $DHR

Nissay Asset Management Corp Japan grew its holdings in shares of Danaher Corporation (NYSE:DHR) by 4.4% during the 2nd quarter, Holdings Channel reports. The institutional investor owned 84,803 shares of the conglomerate’s stock after acquiring an additional 3,596 shares during the quarter. Nissay Asset Management Corp Japan’s holdings in Danaher were worth $16,153,000 at the end of the most recent reporting period.

Other institutional investors have also recently made changes to their positions in the company. Main Street Group LTD bought a new stake in Danaher during the first quarter worth approximately $25,000. N.E.W. Advisory Services LLC purchased a new stake in Danaher during the second quarter valued at approximately $25,000. JPL Wealth Management LLC bought a new stake in shares of Danaher in the 3rd quarter valued at approximately $25,000. WFA of San Diego LLC purchased a new position in shares of Danaher in the 2nd quarter worth approximately $26,000. Finally, Hilton Head Capital Partners LLC purchased a new position in shares of Danaher in the 4th quarter worth approximately $27,000. Institutional investors own 79.05% of the company’s stock.

Analyst Ratings Changes

Several analysts recently weighed in on the company. Stifel Nicolaus decreased their price target on Danaher from $260.00 to $220.00 and set a “buy” rating on the stock in a report on Wednesday, July 22nd. Wells Fargo & Company dropped their price objective on shares of Danaher from $212.00 to $195.00 and set an “equal weight” rating for the company in a research note on Wednesday, July 22nd. Royal Bank Of Canada boosted their price objective on shares of Danaher from $200.00 to $215.00 and gave the company an “outperform” rating in a research report on Wednesday, July 22nd. Citigroup assumed coverage on shares of Danaher in a research note on Tuesday, May 26th. They issued a “buy” rating and a $230.00 target price on the stock. Finally, Wolfe Research lowered shares of Danaher from an “outperform” rating to a “peer perform” rating in a report on Monday, June 1st. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have given a Hold rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $228.91.

Danaher Trading Up 0.3%

Shares of NYSE DHR opened at $216.41 on Friday. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.25 and a current ratio of 1.65. The business’s 50 day moving average price is $199.46 and its 200-day moving average price is $192.52. Danaher Corporation has a fifty-two week low of $160.93 and a fifty-two week high of $242.80. The company has a market cap of $152.13 billion, a price-to-earnings ratio of 38.44, a PEG ratio of 2.69 and a beta of 0.78.

Danaher (NYSE:DHR) last posted its quarterly earnings data on Monday, July 20th. The conglomerate reported $1.94 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.85 by $0.09. The company had revenue of $6.26 billion during the quarter, compared to analysts’ expectations of $6.12 billion. Danaher had a return on equity of 11.04% and a net margin of 15.95%.Danaher’s revenue was up 5.5% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.77 EPS. On average, sell-side analysts expect that Danaher Corporation will post 8.53 earnings per share for the current year.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.